Fat Cell Therapy for Hand Problems in Scleroderma
Part of Skin clinical trials.
This study tests whether a person's own fat cells (processed into regenerative cells) can be injected into the hands to improve hand function and reduce skin thickening in systemic sclerosis (scleroderma). It’s designed for people whose hand problems are significant but not too severe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have been diagnosed with systemic sclerosis (scleroderma), either the diffuse or limited type.
- Your hand skin is thickened and your hand function is limited (Cochin Hand Function Scale score of 20 or more out of 90).
- You are able to safely undergo a liposuction procedure to collect fat cells from your belly or thighs.
- You have not had certain treatments or conditions that would make the study unsafe (e.g., recent cancer, active infections, severe allergies, or other autoimmune diseases).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a skin patch with botulinum toxin to ease blood vessel spasms in the fingers of people with scleroderma, which can cause pain and sores. It may help improve blood flow and reduce finger discomfort.
This trial tests whether special cells from umbilical cord (UC-MSC) can help treat systemic sclerosis—a disease that causes skin and organ hardening. If you have early systemic sclerosis that hasn't improved enough with standard treatments, this study may offer a new option.
This study tests whether blocking a protein called TL1A can help reduce skin thickening and improve the immune system in people with systemic sclerosis (a condition where skin becomes hard and thick). Researchers will compare skin and blood samples from people with systemic sclerosis to healthy volunteers.
This trial tests an investigational drug called efgartigimod in people with systemic sclerosis (scleroderma). The goal is to see if it can safely reduce skin thickening and improve overall health. You might qualify if your skin is moderately affected and you have certain antibodies in your blood.
This trial uses a simple 6-minute pegboard ring test to check how well your hands work. It aims to understand hand function in scleroderma and may help find new ways to track your health.
This research study uses special lab-grown stem cells to understand how systemic sclerosis (a disease that hardens skin and organs) develops and progresses. By studying cells from patients with different types of systemic sclerosis and healthy relatives, researchers hope to find new ways to treat or prevent the disease.
Hear when a new Systemic Sclerosis (SSc) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.